Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
US Market

Lotus Pharmaceuticals (LTUS) Income Statement

4 Followers

Lotus Pharmaceuticals Income Statement

Last quarter (Q ), Lotus Pharmaceuticals's total revenue was $19.04M, an increase of 4.04% from the same quarter last year. In Q, Lotus Pharmaceuticals's net income was $1.25M. See Lotus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 10Dec 09Dec 08Dec 07Dec 06
Total Revenue
$ 71.39M$ 72.70M$ 57.82M$ 73.80M$ 56.87M$ 36.21M
Cost of Revenue
$ 45.94M$ 32.92M$ 25.35M$ 40.65M$ 33.68M$ 26.52M
Gross Profit
$ 25.45M$ 39.78M$ 32.47M$ 33.15M$ 23.19M$ 9.68M
Operating Expense
$ 17.28M$ 18.50M$ 11.43M$ 18.08M$ 11.89M$ 5.26M
Operating Income
$ 8.17M$ 21.29M$ 21.04M$ 15.07M$ 11.31M$ 4.43M
Net Non Operating Interest Income Expense
$ -245.72K$ -609.48K$ -2.11M$ -1.92M--
Other Income Expense
$ -6.43M$ -6.03M$ -2.13M$ -362.09K$ 1.85M-
Pretax Income
$ 1.49M$ 14.65M$ 16.80M$ 12.79M$ 11.22M$ 4.10M
Tax Provision
$ -250.07K$ 220.29K$ 368.68K$ 0.00--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 1.74M$ 14.42M$ 16.43M$ 12.79M$ 11.22M$ 4.10M
Basic EPS
$ 0.06$ 0.28$ 0.74$ 0.60$ 0.54$ 0.20
Diluted EPS
$ 0.05$ 0.27$ 0.66$ 0.54$ 0.52$ 0.20
Basic Average Shares
$ 109.79M$ 52.36M$ 22.10M$ 21.15M$ 20.71M$ 20.18M
Diluted Average Shares
$ 110.72M$ 53.99M$ 25.02M$ 24.03M$ 21.93M$ 20.18M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 63.23M$ 51.41M$ 36.79M$ 58.73M$ 45.56M$ 31.78M
Net Income From Continuing And Discontinued Operation
$ 1.74M$ 14.42M$ 16.43M$ 12.79M$ 11.22M$ 4.10M
Normalized Income
$ 8.08M$ 20.36M$ 18.52M$ 13.15M$ 9.37M$ 4.10M
Interest Expense
$ 248.16K$ 612.63K$ 2.15M$ 1.93M--
EBIT
$ 1.73M$ 15.26M$ 18.96M$ 14.72M$ 11.31M$ 4.43M
EBITDA
$ 3.87M$ 17.51M$ 20.94M$ 15.35M$ 13.54M$ 4.99M
Currency in USD

Lotus Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis